These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 16521406)
1. [Pharmacogenetics of chronic heart failure--beta blockers]. Vasků A; Spinarová L; Pávková-Goldbergová M; Spinar J; Soucek M; Vítovec J Cas Lek Cesk; 2006; 145(2):148-52; discussion 152-3. PubMed ID: 16521406 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286 [TBL] [Abstract][Full Text] [Related]
3. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure]. Huang WY; Sun M; Zhou HY; Pei ZF; Yang TL Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):686-9. PubMed ID: 16114558 [TBL] [Abstract][Full Text] [Related]
4. Gene polymorphism of angiotensin-converting enzyme and angiotensin II type 1 receptor in patients with congestive heart failure. Pop D; Zdrenghea D; Procociuc LM; Popal A Rom J Intern Med; 2007; 45(4):349-54. PubMed ID: 18767410 [TBL] [Abstract][Full Text] [Related]
5. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the plasma angiotensin II levels and the risk of chronic heart failure]. Huang WY; Sun M; Zhou HY Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 29(2):198-200. PubMed ID: 16145913 [TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure. Cuoco MA; Pereira AC; Mota Gde F; Krieger JE; Mansur AJ Arq Bras Cardiol; 2008 Apr; 90(4):252-6. PubMed ID: 18516385 [TBL] [Abstract][Full Text] [Related]
7. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure. Tang WH; Vagelos RH; Yee YG; Fowler MB Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323 [TBL] [Abstract][Full Text] [Related]
8. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery. Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835 [TBL] [Abstract][Full Text] [Related]
9. Relationship between ACE gene polymorphism and ischemic chronic heart failure in Turkish population. Akbulut T; Bilsel T; Terzi S; Ciloglu F; Unal Dayi S; Sayar N; Peker I; Yesilcimen K Eur J Med Res; 2003 Jun; 8(6):247-53. PubMed ID: 12911874 [TBL] [Abstract][Full Text] [Related]
10. Influence of angiotensin-converting enzyme gene insertion/deletion polymorphism on rheumatic valve involvement, valve severity and subsequent valve calcification. Davutoglu V; Nacak M J Heart Valve Dis; 2005 May; 14(3):277-81. PubMed ID: 15974518 [TBL] [Abstract][Full Text] [Related]
11. Effects of ACE gene insertion/deletion polymorphism on response to spironolactone in patients with chronic heart failure. Cicoira M; Rossi A; Bonapace S; Zanolla L; Perrot A; Francis DP; Golia G; Franceschini L; Osterziel KJ; Zardini P Am J Med; 2004 May; 116(10):657-61. PubMed ID: 15121491 [TBL] [Abstract][Full Text] [Related]
12. The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility to chronic pancreatitis. Oruc N; Lamb J; Kutlu OC; Barmada MM; Money ME; Slivka A; Whitcomb DC JOP; 2004 Nov; 5(6):457-63. PubMed ID: 15536282 [TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptor blockade and the angiotensin-converting enzyme deletion polymorphism in patients with chronic heart failure. de Groote P; Helbecque N; Lamblin N; Hermant X; Amouyel P; Bauters C; Dallongeville J Eur J Heart Fail; 2004 Jan; 6(1):17-21. PubMed ID: 15012914 [TBL] [Abstract][Full Text] [Related]
14. [Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril]. Tereshchenko SN; Demidova IV; Kobalava ZhD; Moiseev VS Ter Arkh; 2002; 74(4):56-8. PubMed ID: 12043242 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure. McNamara DM; Holubkov R; Janosko K; Palmer A; Wang JJ; MacGowan GA; Murali S; Rosenblum WD; London B; Feldman AM Circulation; 2001 Mar; 103(12):1644-8. PubMed ID: 11273991 [TBL] [Abstract][Full Text] [Related]
16. Association of angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism with spondylarthropathies. Shehab DK; Al-Jarallah KF; Al-Awadhi AM; Al-Herz A; Nahar I; Haider MZ J Biomed Sci; 2008 Jan; 15(1):61-7. PubMed ID: 17713861 [TBL] [Abstract][Full Text] [Related]
17. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients. Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561 [TBL] [Abstract][Full Text] [Related]